1. Mozaffarian D, Benjamin E, Go A, et al. Correction to: Heart Disease and Stroke Statistics—2017 Update: A Report from the American Heart Association. Circulation . 2017;135(10):e646-e646. doi:10.1161/cir.0000000000000491.
2. Ibid.
3. Gundry S. The Plant Paradox: The Hidden Dangers In "Healthy" Foods That Cause Disease and Weight Gain . 1st ed. New York City, NY: Harper Wave; 2017:4.
4. Rippe J, Angelopoulos T. Sucrose, High-Fructose Corn Syrup, and Fructose, Their Metabolism and Potential Health Effects: What Do We Really Know? Advances in Nutrition: An International Review Journal. 2013;4(2):236-245. doi:10.3945/an.112.002824.
5. Bray G. Fructose: Pure, White, and Deadly? Fructose, by Any other Name, is a Health Hazard. Journal of Diabetes Science and Technology. 2010;4(4):1003-1007. doi:10.1177/193229681000400432.
6. Kolderup A, Svihus B. Fructose Metabolism and Relation to Atherosclerosis, Type 2 Diabetes, and Obesity. Journal of Nutrition and Metabolism. 2015;2015:1-12. doi:10.1155/2015/823081.
7. Stanhope K, Schwarz J, Havel P. Adverse metabolic effects of dietary fructose. Current Opinion in Lipidology. 2013;24(3):198-206. doi:10.1097/mol.0b013e3283613bca.
8. Ibid.
9. Kolderup A, Svihus B. (1-12).
10. Basu S, Yoffe P, Hills N, Lustig R. The Relationship of Sugar to Population-Level Diabetes Prevalence: An Econometric Analysis of Repeated Cross-Sectional Data. PLoS ONE. 2013;8(2):e57873. doi:10.1371/journal.pone.0057873.
11. DiNicolantonio J, Lucan S. The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease. Open Heart. 2014;1(1):e000167. doi:10.1136/openhrt-2014-000167.
12. Ibid.
13. Stanhope K, Schwarz J, Havel P. (198-206).
14. Kolderup A, Svihus B. (1-12).
15. Rippe J, Angelopoulos T. Fructose-Containing Sugars and Cardiovascular Disease. Advances in Nutrition: An International Review Journal. 2015;6(4):430-439. doi:10.3945/an.114.008177.
16.Yang Q, Zhang Z, Gregg E, Flanders W, Merritt R, Hu F. Added Sugar Intake and Cardiovascular Diseases Mortality Among US Adults. JAMA Internal Medicine. 2014;174(4):516. doi:10.1001/jamainternmed.2013.13563.
17. Mozaffarian D, Benjamin E, Go A, et al. Correction to: Heart Disease and Stroke Statistics—2017 Update: A Report from the American Heart Association. Circulation. 2017;135(10):e646-e646. doi:10.1161/cir.0000000000000491.
18. [WHO document] (cvd_atlas_29_world_data_table.pdf
19. World Health Statistics 2016: Monitoring health for the SDGs. World Health Organization. 2016. Available at: http://www.who.int/gho/publications/world_health_statistics/2016/Annex_B/en/. Accessed June 20, 2017.
20. Ibid.
24. Ibid.
22. Page I, Allen E, Chamberlain F, Keys A, Stamler J, Stare F. Dietary Fat and Its Relation to Heart Attacks and Strokes. Circulation. 1961;23(1):133-136. doi:10.1161/01.cir.23.1.133.
23. Teicholz N. Don't believe the American Heart Assn. — butter, steak and coconut oil aren't likely to kill you. latimescom. 2017. Available at: http://www.latimes.com/opinion/op-ed/la-oe-teicholz-saturated-fat-wont-kill-you-20170723-story.html. Accessed July 27, 2017.
24. Do Saturated Fats Really Cause Heart Disease? Science 20. 2014. Available at: http://www.science20.com/news_articles/do_saturated_fats_really_cause_heart_disease-131862. Accessed July 28, 2017.
25. Chowdhury R, Warnakula S, Kunutsor S, et al. Association of Dietary, Circulating, and Supplement Fatty Acids with Coronary Risk. Annals of Internal Medicine. 2014;160(6):398-406. doi:10.7326/m13-1788.
26. Bittman M. Opinion | Butter Is Back. Nytimescom. 2014. Available at: https://www.nytimes.com/2014/03/26/opinion/bittman-butter-is-back.html. Accessed July 28, 2017.
27. Siri-Tarino P, Sun Q, Hu F, Krauss R. Saturated Fatty Acids and Risk of Coronary Heart Disease: Modulation by Replacement Nutrients. Current Atherosclerosis Reports. 2010;12(6):384-390. doi:10.1007/s11883-010-0131-6.
28. Ibid.
29. Kearns C, Schmidt L, Glantz S. Sugar Industry and Coronary Heart Disease Research. JAMA Internal Medicine. 2016;176(11):1680. doi:10.1001/jamainternmed.2016.5394.
30. Iqbal M. Trans fatty acids – a risk factor for cardiovascular disease. Pakistan Journal of Medical Sciences. 2014;30(1):194-197. doi:10.12669/pjms.301.4525.
31. Mozaffarian D, Katan M, Ascherio A, Stampfer M, Willett W. Trans Fatty Acids and Cardiovascular Disease. New England Journal of Medicine. 2006;354(15):1601-1613. doi:10.1056/nejmra054035.
32. Final Determination Regarding Partially Hydrogenated Oils (Removing Trans Fat). Fdagov. 2017. https://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm449162.htm. Accessed July 27, 2017.
33. Gundry S. The Plant Paradox: The Hidden Dangers In "Healthy" Foods That Cause Disease and Weight Gain . 1st ed. New York City, NY: Harper Wave; 2017:45.
34. Clark C. Sourdough Bread Health Benefits Make it the Best Bread Choice. University Health News. 2017. Available at: https://universityhealthnews.com/daily/nutrition/sourdough-bread-health-benefits-make-it-the-best-bread-choice/. Accessed September 1, 2017.
35. Najjar A, Parsons P, Duncan A, et al. The acute impact of ingestion of breads of varying composition on blood glucose, insulin and incretins following first and second meals. British Journal of Nutrition. 2008;101(03):391. doi:10.1017/s0007114508003085.
36. Maioli M, Pes G, Sanna M, et al. Sourdough-leavened bread improves postprandial glucose and insulin plasma levels in subjects with impaired glucose tolerance. Acta Diabetologica. 2008;45(2):91-96. doi:10.1007/s00592-008-0029-8.
37. Mohamed Saleem T, Darbar Basha S. Red wine: A drink to your heart. Journal of Cardiovascular Disease Research. 2010;1(4):171-176. doi:10.4103/0975-3583.74259.
38. Kean B. The Blood Pressure of the Cuna Indians. The American Journal of Tropical Medicine and Hygiene. 1944;s1-24(6):341-343. doi:10.4269/ajtmh.1944.s1-24.341.
39. Hollenberg N, Martinez G, McCullough M, et al. Aging, Acculturation, Salt Intake, and Hypertension in the Kuna of Panama. Hypertension. 1997;29(1):171-176. doi:10.1161/01.hyp.29.1.171.
40. Hollenberg N, Fisher N, McCullough M. Flavanols, the Kuna, cocoa consumption, and nitric oxide. Journal of the American Society of Hypertension. 2009;3(2):105-112. doi:10.1016/j.jash.2008.11.001.
41.Ibid.
42. Hollenberg N, Martinez G, McCullough M, et al. (171-176). doi:10.1161/01.hyp.29.1.171.
43. Ibid.
44. Bayard V, Chamorro F, Motta J, Hollenberg N. Does Flavanol Intake Influence Mortality from Nitric Oxide-Dependent Processes? Ischemic Heart Disease, Stroke, Diabetes Mellitus, and Cancer in Panama. International Journal of Medical Sciences. 2007:53-58. doi:10.7150/ijms.4.53.
45. Hollenberg N, Martinez G, McCullough M, et al. Aging, Acculturation, Salt Intake, and Hypertension in the Kuna of Panama. Hypertension. 1997;29(1):171-176. doi:10.1161/01.hyp.29.1.171.
46. Hollenberg N, Fisher N, McCullough M. Flavanols, the Kuna, cocoa consumption, and nitric oxide. Journal of the American Society of Hypertension. 2009;3(2):105-112. doi:10.1016/j.jash.2008.11.001.
47. Fisher N, Hughes M, Gerhard-Herman M, Hollenberg N. Flavanol-rich cocoa induces nitric-oxide-dependent vasodilation in healthy humans. Journal of Hypertension. 2003;21(12):2281-2286. doi:10.1097/00004872-200312000-00016.
48. Schroeter H, Heiss C, Balzer J et al. (-)-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proceedings of the National Academy of Sciences. 2006;103(4):1024-1029. doi:10.1073/pnas.0510168103.
49. Vlachojannis J, Erne P, Zimmermann B, Chrubasik-Hausmann S. The Impact of Cocoa Flavanols on Cardiovascular Health. Phytotherapy Research . 2016;30(10):1641-1657. doi:10.1002/ptr.5665.
50. Siddiqui A. Effects of Vasodilation and Arterial Resistance on Cardiac Output. Journal of Clinical & Experimental Cardiology. 2011;02(11). doi:10.4172/2155-9880.1000170.
51. Hollenberg N, Fisher N, McCullough M. Flavanols, the Kuna, cocoa consumption, and nitric oxide. Journal of the American Society of Hypertension. 2009;3(2):105-112. doi:10.1016/j.jash.2008.11.001.
52. Ibid.
53. Ibid.
54. Hollenberg N, Martinez G, McCullough M, et al. Aging, Acculturation, Salt Intake, and Hypertension in the Kuna of Panama. Hypertension. 1997;29(1):171-176. doi:10.1161/01.hyp.29.1.171.
55. McCullough M, Chevaux K, Jackson L, et al. Hypertension, the Kuna, and the epidemiology of flavanols. Journal of Cardiovascular Pharmacology. 2006;47(Suppl 2):S103-9. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16794446/ .
56. Ibid.
57. Fisher N, Hughes M, Gerhard-Herman M, Hollenberg N. (2281-2286). doi:10.1097/00004872-200312000-00016.
58. Schroeter H, Heiss C, Balzer J et al. (1024-1029). doi:10.1073/pnas.0510168103.
59. Vlachojannis J, Erne P, Zimmermann B, Chrubasik-Hausmann S. (1641-1657). doi:10.1002/ptr.5665.
60. Hollenberg N, Fisher N, McCullough M. (105-112). doi:10.1016/j.jash.2008.11.001.
61. Buijsse B. Cocoa Intake, Blood Pressure, and Cardiovascular Mortality: The Zutphen Elderly Study. Archives of Internal Medicine. 2006;166(4):411-417. doi:10.1001/.411.
62. Taubert D, Roesen R, Schömig E. Effect of Cocoa and Tea Intake on Blood Pressure. Archives of Internal Medicine. 2007;167(7):626. doi:10.1001/archinte.167.7.626.
63. Hooper L, Kroon P, Rimm E, Cohn J, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition. 2008;88(1):38-50. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18614722/. Accessed July 31, 2017.
64. Kaplan N. Treating prehypertension: A review of the evidence. Current Hypertension Reports. 2008;10(4):326-329. doi:10.1007/s11906-008-0060-8.
65. Taubert D, Roesen R, Schömig E. (626). doi:10.1001/archinte.167.7.626.
66. Hooper L, Kroon P, Rimm E, Cohn J, et al. (38-50). Available at: https://www.ncbi.nlm.nih.gov/pubmed/18614722/. Accessed July 31, 2017.
67. Kaplan N. (326-329). doi:10.1007/s11906-008-0060-8.
68. Hollenberg N. Organ Systems Dependent on Nitric Oxide and the Potential for Nitric Oxide-Targeted Therapies in Related Diseases. The Journal of Clinical Hypertension. 2006;8:63-76. doi:10.1111/j.1524-6175.2006.06042.x.
69. Ibid.
70. Schroeter H, Heiss C, Balzer J et al. (1024-1029). doi:10.1073/pnas.0510168103.
71. Fisher N, Hughes M, Gerhard-Herman M, Hollenberg N. (2281-2286). doi:10.1097/00004872-200312000-00016.
72. Heiss C, Finis D, Kleinbongard P, et al. Sustained Increase in Flow-Mediated Dilation After Daily Intake of High-Flavanol Cocoa Drink Over 1 Week. Journal of Cardiovascular Pharmacology. 2007;49(2):74-80. doi:10.1097/fjc.0b013e31802d0001.
73. Kris-Etherton P, Keen C. Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Current Opinion in Lipidology. 2002;13(1):41 doi:10.1097/00041433-200202000-00007.
74. Hollenberg N, Fisher N, McCullough M. (105-112). doi:10.1016/j.jash.2008.11.001.
75. Monahan K, Feehan R, Kunselman A, et al. Dose-dependent increases in flow-mediated dilation following acute cocoa ingestion in healthy older adults. Journal of Applied Physiology. 2011;111(6):1568-1574. doi:10.1152/japplphysiol.00865.2011.
76. Buijsse B. (411-417). doi:10.1001/.411.
77. Keen C, Holt R, Pteiza P. Cocoa antioxidants and cardiovascular health. The American Journal of Clinical Nutrition. 2005;81(1 Suppl):298S-303S. Available at: http://ajcn.nutrition.org/content/81/1/298S.full. Accessed July 31, 2017.
78. Pucciarelli D. Cocoa and Heart Health: A Historical Review of the Science. Nutrients. 2013;5(10):3854-3870. doi:10.3390/nu5103854.
79. Galleano M, Oteiza P, Fraga C. Cocoa, Chocolate, and Cardiovascular Disease. Journal of Cardiovascular Pharmacology. 2009;54(6):483-490. doi:10.1097/fjc.0b013e3181b76787.
80. Ding E, Hutfless S, Ding X, Girotra S. Chocolate and Prevention of Cardiovascular Disease: A Systematic Review. Nutrition & Metabolism. 2006;3(1):2. doi:10.1186/1743-7075-3-2.
81. Erdman J, Carson L, Kwik-Uribe C, Evans E, Allen R. Effects of cocoa flavanols on risk factors for cardiovascular disease. Asia Pacific Journal of Clinical Nutrition. 2008;17(Suppl 1):284-7. Available at: https://www.ncbi.nlm.nih.gov/pubmed/18296357. Accessed July 31, 2017.
82. Shrime M, Bauer S, McDonald A, Chowdhury N, Coltart C, Ding E. Flavonoid-Rich Cocoa Consumption Affects Multiple Cardiovascular Risk Factors in a Meta-Analysis of Short-Term Studies. Journal of Nutrition. 2011;141(11):1982-1988. doi:10.3945/jn.111.145482.
83.Yang Y, Chan S, Hu M, Walden R, Tomlinson B. Effects of Some Common Food Constituents on Cardiovascular Disease. ISRN Cardiology. 2011;2011:1-16. doi:10.5402/2011/397136.
84. Aprotosoaie A, Miron A, Trifan A, Luca V, Costache I. The Cardiovascular Effects of Cocoa Polyphenols—An Overview. Diseases. 2016;4(4):39. doi:10.3390/diseases4040039.
85. Sansone R, Rodriguez-Mateos A, Heuel J, et al. Cocoa flavanol intake improves endothelial function and Framingham Risk Score in healthy men and women: a randomised, controlled, double-masked trial: the Flaviola Health Study. British Journal of Nutrition. 2015;114(08):1246-1255. doi:10.1017/s0007114515002822.
86. Pucciarelli D. (3854-3870). doi:10.3390/nu5103854.
87. Aprotosoaie A, Luca S, Miron A. Flavor Chemistry of Cocoa and Cocoa Products-An Overview. Comprehensive Reviews in Food Science and Food Safety. 2015;15(1):73-91. doi:10.1111/1541-4337.12180.
88. Patton D. Barry Callebaut chocolate could be good for the brain. NutraIngredientscom. 2005. Available at: http://www.nutraingredients.com/Suppliers2/Barry-Callebaut-chocolate-could-be-good-for-the-brain. Accessed June 5, 2017.
89. Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal. 2012;10(7):2809. doi:10.2903/j.efsa.2012.2809.
90. Pucciarelli D. (3854-3870). doi:10.3390/nu5103854.
91. Ibid.
92. Acticoa™ - FAQ. Acticoacom. 2017. Available at: http://www.acticoa.com/faq#q2. Accessed August 2, 2017.
93. Ibid.
94.Scientific Opinion on… (2809). doi:10.2903/j.efsa.2012.2809.
95. Ibid.
96. Lattimer J, Haub M. Effects of Dietary Fiber and Its Components on Metabolic Health. Nutrients. 2010;2(12):1266-1289. doi:10.3390/nu2121266.
97.Gibson G, Beatty E, Wang X, Cummings J. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology. 1995;108(4):975-982. doi:10.1016/0016-5085(95)90192-2.
98. Marteau P, Jacobs H, Cazaubiel M, Signoret C, Prevel J, Housez B. Effects of chicory inulin in constipated elderly people: a double-blind controlled trial. International Journal of Food Sciences and Nutrition. 2010;62(2):164-170. doi:10.3109/09637486.2010.527323.
99. Gibson G, Beatty E, Wang X, Cummings J. (975-982). doi:10.1016/0016-5085(95)90192-2.
100. Roberfroid M. Introducing inulin-type fructans. British Journal of Nutrition. 2005;93(S1):S13. doi:10.1079/bjn20041350.
101. Marteau P, Jacobs H, Cazaubiel M, et al. (164-170). doi:10.3109/09637486.2010.527323.
102. Lattimer J, Haub M. (1266-1289). doi:10.3390/nu2121266.
103. Cani P, Joly E, Horsmans Y, Delzenne N. Oligofructose promotes satiety in healthy human: a pilot study. European Journal of Clinical Nutrition. 2005;60(5):567-572. doi:10.1038/sj.ejcn.1602350.
104. Heap S, Ingram J, Law M, Tucker A, Wright A. Eight-day consumption of inulin added to a yogurt breakfast lowers postprandial appetite ratings but not energy intakes in young healthy females: a randomised controlled trial. British Journal of Nutrition. 2015;115(02):262-270. doi:10.1017/s0007114515004432.
105. Parnell J, Reimer R. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. American Journal of Clinical Nutrition. 2009;89(6):1751-1759. doi:10.3945/ajcn.2009.27465.
106. B. Nemzer, X. Zhang, Zb Pietrzkowski. Effect of whole coffee fruit extract phytochemicals on antiradical activity and BDNF in healthy subjects. International Symposium on Phytochemicals in Medicine and Food, Shanghai, China. June 26-29, 2016. P. 37.
107. Reyes-Izquierdo T, Nemzer B, Shu C et al. Modulatory effect of coffee fruit extract on plasma levels of brain-derived neurotrophic factor in healthy subjects. British Journal of Nutrition. 2013;110(03):420-425. doi:10.1017/s0007114512005338.
108. Yamada K, Nabeshima T. Brain-Derived Neurotrophic Factor/TrkB Signaling in Memory Processes. Journal of Pharmacological Sciences . 2003;91(4):267-270. doi:10.1254/jphs.91.267.
109. Huang E, Reichardt L. Neurotrophins: Roles in Neuronal Development and Function. Annual Review of Neuroscience. 2001;24(1):677-736. doi:10.1146/annurev.neuro.24.1.677.
110. Brunoni A, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology. 2008;11(8):1169-1180. doi:10.1017/s1461145708009309.
111. Reyes-Izquierdo T, Nemzer B, Argumedo R, Cervantes M, Pietrzkowski Z. Stimulatory Effect Of Acute Single Dose Of Dried Whole Coffee Cherry Powder On Nrf2 Activity In Freshly Isolated Blood Cells. A Single-Blind, Placebo Controlled Cross-Over Pilot Clinical Study. The Journal of Aging Research and Clinical Practice. 2016;5(3):120-127. Available at: http://dx.doi.org/10.14283/jarcp.2016.109. Accessed August 3, 2017.
112. Venugopal R, Jaiswal A. Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H: quinone oxidoreductase1 gene. Proceedings of the National Academy of Sciences. 1996;93(25):14960-14965. doi:10.1073/pnas.93.25.14960.
113. Solis W, Dalton T, Dieter M et al. Glutamate–cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress. Biochemical Pharmacology. 2002;63(9):1739-1754. doi:10.1016/s0006-2952(02)00897-3.
114.Soriano F, Baxter P, Murray L, Sporn M, Gillingwater T, Hardingham G. Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin. Molecules and Cells. 2009;27(3):279-282. doi:10.1007/s10059-009-0050-y.
115. Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. Flax and flaxseed oil: an ancient medicine & modern functional food. Journal of Food Science and Technology. 2014;51(9):1633-1653. doi:10.1007/s13197-013-1247-9.
116. Rodriguez-Leyva D, Bassett C, McCullough R, Pierce G. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Canadian Journal of Cardiology. 2010;26(9):489-496. doi:10.1016/s0828-282x(10)70455-4.
117. Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. (1633-1653). doi:10.1007/s13197-013-1247-9.
118. Slavin J. Fiber and Prebiotics: Mechanisms and Health Benefits. Nutrients. 2013;5(4):1417-1435. doi:10.3390/nu5041417.
119. Gibson G, Probert H, Loo J, Rastall R, Roberfroid M. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutrition Research Reviews. 2004;17(02):259. doi:10.1079/nrr200479.
120. Brahe L, Le Chatelier E, Prifti E et al. Dietary modulation of the gut microbiota – a randomised controlled trial in obese postmenopausal women. British Journal of Nutrition. 2015;114(03):406-417. doi:10.1017/s0007114515001786.
121. Gibson G, Probert H, Loo J, Rastall R, Roberfroid M. (59). doi:10.1079/nrr200479.
122. Ley R. Obesity and the human microbiome. Current Opinion in Gastroenterology. 2010;26(1):5-11. doi:10.1097/mog.0b013e328333d751.
123. Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. (1633-1653). doi:10.1007/s13197-013-1247-9.
124. Kristensen M, Savorani F, Christensen S et al. Flaxseed dietary fibers suppress postprandial lipemia and appetite sensation in young men. Nutrition, Metabolism and Cardiovascular Diseases. 2013;23(2):136-143. doi:10.1016/j.numecd.2011.03.004.
125. Wanders A, van den Borne J, de Graaf C et al. Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials. Obesity Reviews. 2011:no-no. doi:10.1111/j.1467-789x.2011.00895.x.
126. Samra R, Anderson G. Insoluble cereal fiber reduces appetite and short-term food intake and glycemic response to food consumed 75 min later by healthy men. The American Journal of Clinical Nutrition. 2007;86(4):972-979. Available at: https://www.ncbi.nlm.nih.gov/pubmed/17921373. Accessed August 3, 2017.
127. Lattimer J, Haub M. (1266-1289). doi:10.3390/nu2121266.
128. Ibrügger, S., Kristensen, M., Mikkelsen, M., & Astrup, A. (2012). Flaxseed dietary fiber supplements for suppression of appetite and food intake. Appetite, 58(2), 490-495. http://dx.doi.org/10.1016/j.appet.2011.12.024
129.Tucker L, Thomas K. Increasing Total Fiber Intake Reduces Risk of Weight and Fat Gains in Women. Journal of Nutrition. 2009;139(3):576-581. doi:10.3945/jn.108.096685.
130. Du H, van der A D, Boshuizen H et al. Dietary fiber and subsequent changes in body weight and waist circumference in European men and women. American Journal of Clinical Nutrition. 2009;91(2):329-336. doi:10.3945/ajcn.2009.28191.
131.Rodriguez-Leyva D, Bassett C, McCullough R, et al. (489-496). doi:10.1016/s0828-282x(10)70455-4.
132. Prasad K. Flaxseed and Cardiovascular Health. Journal of Cardiovascular Pharmacology. 2009;54(5):369-377. doi:10.1097/fjc.0b013e3181af04e5.
133. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis. 1997;132(1):69-76. doi:10.1016/s0021-9150(97)06110-8.
134. Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M. (1633-1653). doi:10.1007/s13197-013-1247-9.
135. Gebauer S, Psota T, Harris W, Kris-Etherton P. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. The American Journal of Clinical Nutrition. 2006;83(6 Suppl):1526S-1535S. Available at: https://www.ncbi.nlm.nih.gov/pubmed/16841863/. Accessed August 4, 2017.
136. Erkkilä A, Lehto S, Pyörälä K, Uusitupa M. n-3 Fatty acids and 5-y risks of death and cardiovascular disease events in patients with coronary artery disease. The American Journal of Clinical Nutrition. 2003;78(1):65-71. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12816772/. Accessed August 4, 2017.
137. Albert C. Dietary -Linolenic Acid Intake and Risk of Sudden Cardiac Death and Coronary Heart Disease. Circulation. 2005;112(21):3232-3238. doi:10.1161/circulationaha.105.572008.
138. Djousse L. Dietary Linolenic Acid Is Inversely Associated With Calcified Atherosclerotic Plaque in the Coronary Arteries: The National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 2005;111(22):2921-2926. doi:10.1161/circulationaha.104.489534.
139. Djousse L, Pankow J, Eckfeldt J, et al. Relation between dietary linolenic acid and coronary artery disease in the National Heart, Lung, and Blood Institute Family Heart Study. The American Journal of Clinical Nutrition. 2001;74(5):612-9. Available at: https://www.ncbi.nlm.nih.gov/pubmed/11684529. Accessed August 4, 2017.
140. Oda E, Hatada K, Katoh K, Kodama M, Nakamura Y, Aizawa Y. A Case-control Pilot Study on n-3 Polyunsaturated Fatty Acid as a Negative Risk Factor for Myocardial Infarction. International Heart Journal . 2005;46(4):583-591. doi:10.1536/ihj.46.583.
141. Ascherio A, Rimm E, Giovannucci E, Spiegelman D, Stampfer M, Willett W. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ. 1996;313(7049):84-90. doi:10.1136/bmj.313.7049.84.
142. Rodriguez-Leyva D, Bassett C, McCullough R, et al. (489-496). doi:10.1016/s0828-282x(10)70455-4.
143.Djousse L, Folsom A, Province M. et al. Dietary linolenic acid and carotid atherosclerosis: the National Heart, Lung, and Blood Institute Family Heart Study. The American Journal of Clinical Nutrition. 2003;77(4):819-25. Available at: https://www.ncbi.nlm.nih.gov/pubmed/12663278/. Accessed August 4, 2017.
144. Kristensen M, Jensen M, Aarestrup J et al. Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion, but magnitude of effect depend on food type. Nutrition & Metabolism. 2012;9(1):8. doi:10.1186/1743-7075-9-8.
145. Cunnane S, Ganguli S, Menard C et al. High α-linolenic acid flaxseed (Linum usitatissimum):some nutritional properties in humans. British Journal of Nutrition. 1993;69(02):443. doi:10.1079/bjn19930046.
146. Cunnane S, Hamadeh M, Liede A, Thompson L, Wolever T, Jenkins D. Nutritional attributes of traditional flaxseed in healthy young adults. The American Journal of Clinical Nutrition. 1995;61(1):62-68. Available at: https://www.ncbi.nlm.nih.gov/pubmed/7825540. Accessed August 4, 2017.
147. Clark W, Parbtani A, Huff M et al. Flaxseed: A potential treatment for lupus nephritis. Kidney International. 1995;48(2):475-480. doi:10.1038/ki.1995.316.
148. Bloedon L, Balikai S, Chittams J et al. Flaxseed and Cardiovascular Risk Factors: Results from a Double Blind, Randomized, Controlled Clinical Trial. Journal of the American College of Nutrition. 2008;27(1):65-74. doi:10.1080/07315724.2008.10719676.
149. Prasad K. (369-377). doi:10.1097/fjc.0b013e3181af04e5.
150. Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal. 2012;10(7):2809. doi:10.2903/j.efsa.2012.2809.